Development of a disease-specific quality of life questionnaire for patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria (QLQ-AA/PNH)—report on phases I and II Martha GrothSusanne SingerJens Panse Original Article Open access 11 November 2016 Pages: 171 - 181
The epidemiologic transition of thalassemia and associated hemoglobinopathies in southern Taiwan Hui-Ching WangLi-Ling HsiehTa-Chih Liu Original Article 28 November 2016 Pages: 183 - 188
Microparticles from splenectomized β-thalassemia/HbE patients play roles on procoagulant activities with thrombotic potential Phatchanat KlaihmonKunwadee PhongpaoPornthip Chaichompoo Original Article 29 November 2016 Pages: 189 - 198
Cognitive and fine motor deficits in a pediatric sickle cell disease cohort of mixed ethnic origin Luise BurkhardtStephan LobitzPablo Hernáiz Driever Original Article 29 October 2016 Pages: 199 - 213
Prognostic significance of IKZF1 deletion in adult B cell acute lymphoblastic leukemia: a meta-analysis Wanhua ZhangPu KuangYu Wang Original Article 04 November 2016 Pages: 215 - 225
Polymorphisms in cytokine genes as prognostic markers in diffuse large B cell lymphoma patients treated with (R)-CHOP Duo LiuYuhui WangYan Jin Original Article 07 November 2016 Pages: 227 - 235
Peripheral blood lymphocyte/monocyte ratio following completion of first-line therapy predicts early relapse in patients with diffuse large B cell lymphoma Shu-Juan ZhouYong-Yong MaKang Yu Original Article 02 November 2016 Pages: 237 - 243
Gemcitabine, dexamethasone, and cisplatin (GDP) as salvage chemotherapy for patients with relapsed or refractory peripheral T cell lymphoma—not otherwise specified Fei QiMei DongYuankai Shi Original Article 17 November 2016 Pages: 245 - 251
Health-related quality of life and symptoms in patients with rituximab-refractory indolent non-Hodgkin lymphoma treated in the phase III GADOLIN study with obinutuzumab plus bendamustine versus bendamustine alone Bruce D. ChesonPeter C. TraskLaurie H. Sehn Original Article Open access 30 November 2016 Pages: 253 - 259
History of autoimmune disease is associated with impaired survival in multiple myeloma and monoclonal gammopathy of undetermined significance: a population-based study Ebba K. LindqvistOla LandgrenSigurdur Y. Kristinsson Original Article Open access 02 November 2016 Pages: 261 - 269
Efficacy and safety of autologous hematopoietic cell transplantation in elderly patients with multiple myeloma: a retrospective national multi-site cohort study Yael C CohenTsila ZuckermanRon Ram Original Article 30 December 2016 Pages: 271 - 278
The long-term outcome of reduced-intensity allogeneic stem cell transplantation from a matched related or unrelated donor, or haploidentical family donor in patients with leukemia: a retrospective analysis of data from the China RIC Cooperative Group Chang-Lin YuZheng-DongHui-Sheng Ai Original Article 18 November 2016 Pages: 279 - 288
Role of reduced-intensity conditioning allogeneic hematopoietic cell transplantation in older patients with de novo acute myeloid leukemia Satoshi YamasakiAkihiro HirakawaShingo Yano Original Article 12 November 2016 Pages: 289 - 297
Altered immune reconstitution of B and T cells precedes the onset of clinical symptoms of chronic graft-versus-host disease and is influenced by the type of onset E.-M. BohmannU. FehnD. Wolff Original Article 09 December 2016 Pages: 299 - 310
Predicting risk factors for varicella zoster virus infection and postherpetic neuralgia after hematopoietic cell transplantation using ordered logistic regression analysis Yuko KanbayashiYosuke MatsumotoMasafumi Taniwaki Original Article 28 November 2016 Pages: 311 - 315
Calreticulin mutations are exceedingly rare in patients with myelodysplastic syndromes with myelofibrosis Julia MontoroCristina RobledoFernando Ramos Letter to the Editor 12 October 2016 Pages: 317 - 318
Mycophenolate mofetil is effective only for involved skin in the treatment for steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation Kenichiro HattoriNoriko DokiKazuteru Ohashi Letter to the Editor 21 October 2016 Pages: 319 - 321
Outcome of allogeneic hematopoietic stem cell transplantation in cases of mature T/NK-cell neoplasms: a single-center retrospective analysis Hiroyuki YamazakiKazunari AokiAkifumi Takaori-Kondo Letter to the Editor 20 October 2016 Pages: 323 - 326
HLA-haploidentical hematopoietic stem cell transplantation with low-dose thymoglobulin GVHD prophylaxis for an adult T cell leukemia/lymphoma patient treated with pretransplant mogamulizumab Makoto HirosawaTakehiro HigashiJunichi Tsukada Letter to the Editor Open access 21 October 2016 Pages: 327 - 328
The importance of erythroblast enumeration in myeloid neoplasia Amer M. ZeidanMina XuDavid P. Steensma Letter to the Editor 23 October 2016 Pages: 329 - 330
High serum levels of complements C3 and C4 as novel markers for myeloma bone disease Fengjuan JiangHui LiuRong Fu Letter to the Editor 07 December 2016 Pages: 331 - 333
BCR-ABL-positive acute myeloid leukemia: About one case treated with ponatinib Heiblig MaëlBidet AudreyPigneux Arnaud Letter to the Editor 20 October 2016 Pages: 335 - 336
Erratum to: BCR-ABL-positive acute myeloid leukemia: About one case treated with ponatinib Maël HeibligAudrey BidetArnaud Pigneux Erratum 19 November 2016 Pages: 337 - 337